This work investigates an optimal control framework for a tumor–immune–chemotherapy model to explore strategies that improve treatment outcomes while minimizing drug toxicity. We consider a system of nonlinear ordinary differential equations describing the interactions among tumor cells, immune cells, and chemotherapeutic drug concentration. Pontryagin’s Maximum Principle is applied to derive the necessary conditions for optimal treatment strategies. A sensitivity analysis is performed to evaluate the influence of key biological parameters on treatment outcomes and to assess the robustness of the optimal control strategy. The results highlight the importance of treatment timing and dosage scheduling in achieving effective cancer control.